Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Graft vs Host Disease × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Graft vs Host Disease 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

ibrutinib 2 ruxolitinib 1 axatilimab 1 Prednisone 1 Methylprednisolone 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02953678 2021-11-24

A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Incyte Corporation

Phase 2 Completed

71 enrolled 24 charts 1 FDA

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡